TRIANA Biomedicines
Aleksandra (Sasha) Zagulyaeva, PhD, is an accomplished scientist with extensive experience in biomedicine and chemical biology. Currently serving as Scientist II at TRIANA Biomedicines since October 2022, Aleksandra leads discovery efforts. Previously, as a Postdoctoral Research Scientist at Novartis Institutes for BioMedical Research from January 2020 to October 2022, Aleksandra independently managed multiple projects in synthetic biology and gene editing, contributing to platform development and project acceleration. Aleksandra's academic background includes a PhD in Chemical Biology from the University of Florida, where significant research focused on protein-protein interactions and nonribosomal peptide biosynthesis. With a strong foundation in organic chemistry and teaching experience, Aleksandra has developed and refined methodologies across various institutions, including Gained at the University of Minnesota Duluth and Moscow State University.
This person is not in any offices
TRIANA Biomedicines
Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease targets that are difficult to address with any other modality. Triana’s drug discovery engine is powered by high-resolution structural insights, state-of-the-art in silico tools, and bespoke chemical libraries. The research team has validated thebest-in-class platform and initiated multiple programs across different disease areas.